Weimai Medical Technology (Wuxi) Co., Ltd. announced that it has received round of funding led by new investor CDH Investment Management Company Limited on March 15, 2024. The transaction included the participation from returning investor Yunnan Botanee Bio-Technology Group Co.LTD.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
59.91 CNY | -3.04% | +4.81% | -12.12% |
04-29 | Jefferies Adjusts Yunnan Botanee Bio-Technology’s Price Target to 62 Yuan From 87 Yuan, Keeps at Hold | MT |
04-26 | Yunnan Botanee Bio-Technology Group Co.LTD Proposes Final Dividend for 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.12% | 3.49B | |
+0.62% | 261B | |
+19.64% | 20.69B | |
0.00% | 18.4B | |
+6.07% | 11.56B | |
-10.06% | 9.69B | |
+17.79% | 7.66B | |
+14.08% | 6.19B | |
+2.13% | 4.62B | |
-15.27% | 3.91B |
- Stock Market
- Equities
- 300957 Stock
- News Yunnan Botanee Bio-Technology Group Co.LTD
- Weimai Medical Technology Co., Ltd. announced that it has received funding from CDH Investment Management Company Limited, Yunnan Botanee Bio-Technology Group Co.LTD